Friday, July 31, 2026

Health Ministry to build “fast track” for commercialization of AI digital medical devices

The government launches a "fast track" for AI medical devices to ease market entry and enhance clinical adoption, with $300M allocated.

Samsung Bioepis Signs Teva Deal to Commercialize Opuviz in Canada, Expanding North American Biosimilar Business

Samsung Bioepis partners with Teva to launch ophthalmology biosimilar Opuviz in Canada, enhancing access to treatments for patients.

Tag: Perplexity AI

Perplexity AI Launches Comet Plus, Revenue-Sharing Model for News Content

Perplexity AI launches Comet Plus, a subscription service that compensates news outlets for article usage, addressing copyright concerns.

Top News

- Our Sponsors Ad -

Follow us